Hypoxia refers to inadequate oxygen delivery to the body's tissues. The body's organs run on less oxygen than they need, and if it continues long enough, damage accrues — especially to the heart, brain, and pulmonary blood vessels.
Hypoxia can be acute (pneumonia, pulmonary embolism, asthma attack) or chronic (long-standing lung disease like COPD or pulmonary fibrosis). We measure it with a pulse oximeter reading SpO₂, or with an arterial blood gas reading PaO₂.
Continuous oxygen (~19 hours/day) vs. nocturnal-only oxygen (~12 hours/day) in patients with severe COPD and chronic hypoxia. At 24 months, continuous oxygen patients had roughly half the mortality of nocturnal-only patients. The strongest evidence in pulmonary medicine for an intervention that requires daily commitment.
Hypoxia refers to inadequate oxygen delivery to the body's tissues. It can be acute (sudden onset, from pneumonia, pulmonary embolism, or asthma attack) or chronic (from long-standing lung disease like COPD or pulmonary fibrosis). Either way, the body's organs run on less oxygen than they need, and if it continues long enough, damage accrues — especially to the heart, brain, and pulmonary blood vessels.
Mild hypoxia can be silent. Moderate hypoxia causes shortness of breath, fatigue, decreased exercise tolerance, headaches, and impaired concentration. Severe hypoxia causes confusion, cyanosis (bluish color to lips and fingertips), and at the extreme, organ failure. Patients with chronic hypoxia often develop pulmonary hypertension (high pressure in the lung blood vessels) and right-sided heart failure (cor pulmonale) — these are the complications that drive long-term mortality.
Pulse oximetry is the first measurement. A resting SpO2 of 92% or higher is generally reassuring; 88% or lower at rest qualifies for supplemental oxygen under Medicare guidelines. Many patients with COPD or ILD also desaturate with exertion or during sleep without realizing it — so we measure SpO2 during a 6-minute walk and often with overnight oximetry. If chronic hypoxia is confirmed, we evaluate for the underlying cause and assess for complications (echocardiogram for right heart strain).
The mainstay is supplemental oxygen. The dose is titrated to maintain SpO2 above ~90% during the activities that cause desaturation. For severe chronic hypoxia, continuous oxygen therapy — 15 or more hours per day — improves survival. This is one of the few interventions in COPD with a proven mortality benefit. We also treat the underlying disease: optimize COPD or ILD therapy, address sleep apnea, treat heart failure, manage pulmonary hypertension.
This page is general medical information, not personalized medical advice. If you have questions about your specific health, talk with your Nimbus clinician.
